Lack of effect of a new spasmolytic agent, rociverine, on intraocular pressure, pupil size and iridocorneal angle in patients with angle-closure glaucoma

Twenty patients with angle-closure glaucoma (38 glaucomatous eyes - 17 surgically operated, 21 non-operated) were treated with rociverine (60 mg orally per day for 7 days), a new direct myolitic and mildly anticholinergic antispasmodic drug. Intraocular pressure, pupil size, iridocorneal angle, bloo...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC). - 1995. - 3(1983), 7 vom: 03., Seite 445-50
1. Verfasser: Pardini, M (VerfasserIn)
Weitere Verfasser: Saponati, G
Format: Aufsatz
Sprache:English
Veröffentlicht: 1983
Zugriff auf das übergeordnete Werk:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
Schlagworte:Journal Article Bridged Bicyclo Compounds Bridged-Ring Compounds Cyclohexanecarboxylic Acids Parasympatholytics rociverine VI08KS44V0
LEADER 01000naa a22002652 4500
001 NLM066465109
003 DE-627
005 20231221233912.0
007 tu
008 231221s1983 xx ||||| 00| ||eng c
028 5 2 |a pubmed24n0222.xml 
035 |a (DE-627)NLM066465109 
035 |a (NLM)6669589 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Pardini, M  |e verfasserin  |4 aut 
245 1 0 |a Lack of effect of a new spasmolytic agent, rociverine, on intraocular pressure, pupil size and iridocorneal angle in patients with angle-closure glaucoma 
264 1 |c 1983 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 30.03.1984 
500 |a Date Revised 23.11.2016 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Twenty patients with angle-closure glaucoma (38 glaucomatous eyes - 17 surgically operated, 21 non-operated) were treated with rociverine (60 mg orally per day for 7 days), a new direct myolitic and mildly anticholinergic antispasmodic drug. Intraocular pressure, pupil size, iridocorneal angle, blood pressure and heart rate were checked before and during treatment. No clinically significant variations were observed in the parameters tested. It is suggested, therefore, that rociverine may be administered, if necessary, even to patients with angle-closure glaucoma 
650 4 |a Journal Article 
650 7 |a Bridged Bicyclo Compounds  |2 NLM 
650 7 |a Bridged-Ring Compounds  |2 NLM 
650 7 |a Cyclohexanecarboxylic Acids  |2 NLM 
650 7 |a Parasympatholytics  |2 NLM 
650 7 |a rociverine  |2 NLM 
650 7 |a VI08KS44V0  |2 NLM 
700 1 |a Saponati, G  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)  |d 1995  |g 3(1983), 7 vom: 03., Seite 445-50  |w (DE-627)NLM023961570 
773 1 8 |g volume:3  |g year:1983  |g number:7  |g day:03  |g pages:445-50 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_121 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 3  |j 1983  |e 7  |b 03  |h 445-50